The current recommendation that an HbA1c of ≥48 mmol/mol is diagnostic of diabetes could mean many more patients with GCK mutation related hyperglycaemia will be misdiagnosed with either T1D or T2D compared with using FPG or 2-hour OGTT values and be inappropriately treated. The gene discussed is GCK; the disease is diabetes mellitus.